Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Stryker Corporation (SYK)

    Price:

    385.37 USD

    ( - -0.69 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    SYK
    Name
    Stryker Corporation
    Industry
    Medical - Devices
    Sector
    Healthcare
    Price
    385.370
    Market Cap
    147.477B
    Enterprise value
    145.180B
    Currency
    USD
    Ceo
    Kevin A. Lobo
    Full Time Employees
    53000
    Ipo Date
    1980-03-17
    City
    Portage
    Address
    2825 Airview Boulevard

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    STERIS plc

    VALUE SCORE:

    9

    Symbol
    STE
    Market Cap
    24.998B
    Industry
    Medical - Devices
    Sector
    Healthcare

    2nd position

    Inspire Medical Systems, Inc.

    VALUE SCORE:

    11

    Symbol
    INSP
    Market Cap
    1.977B
    Industry
    Medical - Devices
    Sector
    Healthcare

    The best

    Globus Medical, Inc.

    VALUE SCORE:

    11

    Symbol
    GMED
    Market Cap
    13.061B
    Industry
    Medical - Devices
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    45.411
    P/S
    5.872
    P/B
    6.575
    Debt/Equity
    0.663
    EV/FCF
    36.966
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    6.304
    Earnings yield
    0.022
    Debt/assets
    0.311
    FUNDAMENTALS
    Net debt/ebidta
    1.943
    Interest coverage
    8.086
    Research And Developement To Revenue
    0.064
    Intangile to total assets
    0.522
    Capex to operating cash flow
    0.151
    Capex to revenue
    0.030
    Capex to depreciation
    0.625
    Return on tangible assets
    0.142
    Debt to market cap
    0.101
    Piotroski Score
    5.000
    FUNDAMENTALS
    PEG
    4.497
    P/CF
    29.276
    P/FCF
    34.495
    RoA %
    6.785
    RoIC %
    10.119
    Gross Profit Margin %
    63.541
    Quick Ratio
    1.212
    Current Ratio
    1.893
    Net Profit Margin %
    12.924
    Net-Net
    -40.888
    FUNDAMENTALS PER SHARE
    FCF per share
    11.197
    Revenue per share
    65.663
    Net income per share
    8.486
    Operating cash flow per share
    13.187
    Free cash flow per share
    11.197
    Cash per share
    10.719
    Book value per share
    58.614
    Tangible book value per share
    -6.672
    Shareholders equity per share
    58.614
    Interest debt per share
    40.669
    TECHNICAL
    52 weeks high
    404.870
    52 weeks low
    329.160
    Current trading session High
    388.670
    Current trading session Low
    381.750
    DIVIDEND
    Dividend yield
    0.882%
    Payout ratio
    39.6%
    Years of div. Increase
    27.000
    Years of div.
    35.000
    Q-shift
    1.000
    Dividend per share
    3.400
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - General
    Dividend yield
    0.025465952%
    Payout Ratio
    66.450524%
    P/E
    26.515
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    38.863
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0.006113871%
    Payout Ratio
    24.29441%
    P/E
    40.974
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - General
    Dividend yield
    0.02197955%
    Payout Ratio
    47.109282%
    P/E
    20.983
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Care Facilities
    Dividend yield
    0.0054765344%
    Payout Ratio
    10.008844%
    P/E
    17.884
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Distribution
    Dividend yield
    0.003140233%
    Payout Ratio
    8.548387%
    P/E
    27.662
    logo

    Country
    IE
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0.029166237%
    Payout Ratio
    78.630257%
    P/E
    26.962
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - General
    Dividend yield
    0.063468635%
    Payout Ratio
    94.28571500000001%
    P/E
    19.820
    logo

    Country
    FR
    Sector
    Healthcare
    Industry
    Drug Manufacturers - General
    Dividend yield
    0.045752846%
    Payout Ratio
    0%
    P/E
    12.797
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    30.837
    DESCRIPTION

    Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

    NEWS
    https://images.financialmodelingprep.com/news/aster-capital-management-difc-ltd-has-129-million-position-20260227.png
    Aster Capital Management DIFC Ltd Has $1.29 Million Position in Stryker Corporation $SYK

    defenseworld.net

    2026-02-27 03:30:54

    Aster Capital Management DIFC Ltd cut its stake in shares of Stryker Corporation (NYSE: SYK) by 44.3% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,491 shares of the medical technology company's stock after selling 2,779 shares during

    https://images.financialmodelingprep.com/news/stryker-corporation-nysesyk-given-consensus-recommendation-of-moderate-buy-20260227.png
    Stryker Corporation (NYSE:SYK) Given Consensus Recommendation of “Moderate Buy” by Brokerages

    defenseworld.net

    2026-02-27 01:42:47

    Shares of Stryker Corporation (NYSE: SYK - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eighteen analysts that are currently covering the stock, MarketBeat.com reports. Five analysts have rated the stock with a hold rating and thirteen have issued a buy rating on the company. The average 1 year target

    https://images.financialmodelingprep.com/news/stryker-launches-synchfix-evt-for-flexible-syndesmotic-fixation-20260225.jpg
    Stryker Launches Synchfix EVT for Flexible Syndesmotic Fixation

    zacks.com

    2026-02-25 13:01:34

    SYK launches Synchfix EVT, a next-gen ankle fixation system designed to streamline surgery and expand reach into adolescent trauma care.

    https://images.financialmodelingprep.com/news/fox-run-management-llc-takes-position-in-stryker-corporation-20260225.png
    Fox Run Management L.L.C. Takes Position in Stryker Corporation $SYK

    defenseworld.net

    2026-02-25 04:52:45

    Fox Run Management L.L.C. bought a new position in shares of Stryker Corporation (NYSE: SYK) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 6,208 shares of the medical technology company's stock, valued at approximately $2,295,000. Stryker accounts for approximately

    https://images.financialmodelingprep.com/news/stryker-launches-synchfix-evt-expanding-options-for-flexible-syndesmotic-20260224.jpg
    Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation

    prnewswire.com

    2026-02-24 08:41:00

    Elevating care with Stryker's next generation device, Synchfix EVT, which will be featured at the 2026 American College of Foot and Ankle Surgeons (ACFAS) Annual Meeting PORTAGE, Mich., Feb. 24, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of Synchfix™ EVT, its next-generation flexible syndesmotic fixation device designed to simplify surgical deployment while supporting ankle stabilization in patients with syndesmotic disruptions.

    https://images.financialmodelingprep.com/news/dana-investment-advisors-inc-has-992-million-stock-holdings-20260224.png
    Dana Investment Advisors Inc. Has $9.92 Million Stock Holdings in Stryker Corporation $SYK

    defenseworld.net

    2026-02-24 04:41:20

    Dana Investment Advisors Inc. grew its holdings in shares of Stryker Corporation (NYSE: SYK) by 72.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,839 shares of the medical technology company's stock after buying an additional 11,289 shares during

    https://images.financialmodelingprep.com/news/granite-investment-partners-llc-reduces-position-in-stryker-corporation-20260223.png
    Granite Investment Partners LLC Reduces Position in Stryker Corporation $SYK

    defenseworld.net

    2026-02-23 04:04:52

    Granite Investment Partners LLC trimmed its holdings in Stryker Corporation (NYSE: SYK) by 4.9% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 58,118 shares of the medical technology company's stock after selling 3,024 shares during the period. Stryker

    https://images.financialmodelingprep.com/news/china-universal-asset-management-co-ltd-makes-new-investment-20260221.png
    China Universal Asset Management Co. Ltd. Makes New Investment in Stryker Corporation $SYK

    defenseworld.net

    2026-02-21 04:29:03

    China Universal Asset Management Co. Ltd. bought a new stake in Stryker Corporation (NYSE: SYK) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 2,000 shares of the medical technology company's stock, valued at approximately $741,000. Other institutional investors have also modified their

    https://images.financialmodelingprep.com/news/contrasting-avivagen-otcmktsvivxf-stryker-nysesyk-20260220.png
    Contrasting Avivagen (OTCMKTS:VIVXF) & Stryker (NYSE:SYK)

    defenseworld.net

    2026-02-20 03:39:27

    Stryker (NYSE: SYK - Get Free Report) and Avivagen (OTCMKTS:VIVXF - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability. Institutional and Insider Ownership 77.1% of Stryker shares are held

    https://images.financialmodelingprep.com/news/fiserv-inc-a-significant-move-in-jeff-auxiers-portfolio-20260217.png
    Fiserv Inc: A Significant Move in Jeff Auxier's Portfolio

    gurufocus.com

    2026-02-17 18:09:00

    Exploring the Strategic Investment Decisions of a Renowned Value Investor Jeff Auxier (Trades, Portfolio) recently submitted the 13F filing for the fourth quar

    https://images.financialmodelingprep.com/news/stryker-launches-t2-alpha-humerus-nailing-system-for-fracture-20260212.jpg
    Stryker Launches T2 Alpha Humerus Nailing System for Fracture Care

    zacks.com

    2026-02-12 14:01:07

    SYK launches the T2 Alpha Humerus Nailing System to enhance complex fracture care, boosting procedural efficiency and strengthening its trauma portfolio.

    https://images.financialmodelingprep.com/news/alps-advisors-inc-decreases-stock-position-in-stryker-corporation-20260212.png
    Alps Advisors Inc. Decreases Stock Position in Stryker Corporation $SYK

    defenseworld.net

    2026-02-12 04:28:51

    Alps Advisors Inc. decreased its position in shares of Stryker Corporation (NYSE: SYK) by 54.6% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,012 shares of the medical technology company's stock after selling 3,622 shares during the period. Alps Advisors Inc.'s

    https://images.financialmodelingprep.com/news/gehc-or-syk-which-is-the-better-value-stock-20260211.jpg
    GEHC or SYK: Which Is the Better Value Stock Right Now?

    zacks.com

    2026-02-11 12:41:24

    Investors with an interest in Medical - Products stocks have likely encountered both GE HealthCare Technologies (GEHC) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?

    https://images.financialmodelingprep.com/news/stryker-launches-t2-alpha-humerus-nailing-system-supporting-surgical-20260211.jpg
    Stryker launches T2 Alpha Humerus Nailing System, supporting surgical workflow and care for complex fractures

    prnewswire.com

    2026-02-11 09:03:00

    PORTAGE, Mich., Feb. 11, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of the T2 Alpha Humerus Nailing System, the latest addition to its T2 Alpha portfolio.

    https://images.financialmodelingprep.com/news/cibc-world-market-inc-sells-9479-shares-of-stryker-20260211.png
    Cibc World Market Inc. Sells 9,479 Shares of Stryker Corporation $SYK

    defenseworld.net

    2026-02-11 04:22:51

    Cibc World Market Inc. lessened its holdings in Stryker Corporation (NYSE: SYK) by 6.3% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 141,032 shares of the medical technology company's stock after selling 9,479 shares during the quarter. Cibc World Market Inc.'s holdings

    https://images.financialmodelingprep.com/news/advisors-asset-management-inc-buys-2197-shares-of-stryker-20260211.png
    Advisors Asset Management Inc. Buys 2,197 Shares of Stryker Corporation $SYK

    defenseworld.net

    2026-02-11 03:36:55

    Advisors Asset Management Inc. increased its stake in shares of Stryker Corporation (NYSE: SYK) by 7.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 32,644 shares of the medical technology company's stock after acquiring an additional 2,197 shares during